Work

Cost-effectiveness of immunomodulators versus infliximab for adults with moderate-to-severe ulcerative colitis.

Year: 2011

Type: article

Source: Inflammatory Bowel Diseases

DOI: 10.1093/ibd/17.supplement1.s53b

Authors: D Malone, J Hurwitz, J Lofland, B Nejadnik, J Vanderpoel, H Waters

Institutions: University of Arizona, Johnson & Johnson (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2774709777

FWCI: 0.398

Cites:

Cited by: 3

Related to: 10